Bristol-Myers Squibb Pharma EEIG
34 products tracked · names used in filings: Bristol-Myers Squibb Pharma EEIG, Bristol Myers Squibb Pharma EEIG
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | DuoCover clopidogrel;acetylsalicylic acid | Application withdrawn | |
| 🇪🇺 | Ixempra | Application withdrawn | |
| 🇪🇺 | Augtyro repotrectinib | Authorised | 2025-01-13 |
| 🇪🇺 | Krazati adagrasib | Authorised | 2024-01-05 |
| 🇪🇺 | Camzyos mavacamten | Authorised | 2023-06-26 |
| 🇪🇺 | Sotyktu deucravacitinib | Authorised | 2023-03-24 |
| 🇪🇺 | Opdualag relatlimab;nivolumab | Authorised | 2022-09-15 |
| 🇪🇺 | Breyanzi lisocabtagene maraleucel | Authorised | 2022-04-04 |
| 🇪🇺 | Abecma idecabtagene vicleucel | Authorised | 2021-08-18 |
| 🇪🇺 | Onureg azacitidine | Authorised | 2021-06-17 |
| 🇪🇺 | Inrebic fedratinib | Authorised | 2021-02-08 |
| 🇪🇺 | Reblozyl luspatercept | Authorised | 2020-06-25 |
| 🇪🇺 | Zeposia ozanimod | Authorised | 2020-05-20 |
| 🇪🇺 | Empliciti elotuzumab | Authorised | 2016-05-11 |
| 🇪🇺 | Nivolumab BMS nivolumab | Withdrawn | 2015-07-20 |
| 🇪🇺 | Evotaz atazanavir;cobicistat | Authorised | 2015-07-13 |
| 🇪🇺 | Opdivo nivolumab | Authorised | 2015-06-19 |
| 🇪🇺 | Daklinza daclatasvir | Expired | 2014-08-22 |
| 🇪🇺 | Imnovid (previously Pomalidomide Celgene) pomalidomide | Authorised | 2013-08-05 |
| 🇪🇺 | Yervoy ipilimumab | Authorised | 2011-07-13 |
| 🇪🇺 | Nulojix belatacept | Authorised | 2011-06-17 |
| 🇪🇺 | Vidaza azacitidine | Authorised | 2008-12-17 |
| 🇪🇺 | Clopidogrel BMS clopidogrel | Withdrawn | 2008-07-16 |
| 🇪🇺 | Thalidomide BMS (previously Thalidomide Celgene) thalidomide | Authorised | 2008-04-16 |
| 🇪🇺 | Abraxane paclitaxel | Authorised | 2008-01-11 |
| 🇪🇺 | Revlimid lenalidomide | Authorised | 2007-06-14 |
| 🇪🇺 | Orencia abatacept | Authorised | 2007-05-21 |
| 🇪🇺 | Irbesartan Hydrochlorothiazide BMS irbesartan;hydrochlorothiazide | Withdrawn | 2007-01-19 |
| 🇪🇺 | Irbesartan BMS irbesartan | Withdrawn | 2007-01-19 |
| 🇪🇺 | Sprycel dasatinib (anhydrous) | Authorised | 2006-11-20 |
| 🇪🇺 | Baraclude entecavir | Authorised | 2006-06-26 |
| 🇪🇺 | Reyataz atazanavir sulfate | Authorised | 2004-03-01 |
| 🇪🇺 | Sustiva efavirenz | Withdrawn | 1999-05-28 |
| 🇪🇺 | Zerit stavudine | Withdrawn | 1996-05-08 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.